Type 2 diabetes and bone fragility- An under-recognized association.
Khalid J Farooqui1, Ambrish Mithal1, Ann Kwee Kerwen2
1Max Institute of Endocrinology and Diabetes, Max Super Speciality Hospital, Saket, Delhi, India.
Diabetes & Metabolic Syndrome
|May 1, 2021
Summary
Type 2 diabetes (T2DM) increases fracture risk due to skeletal fragility, often missed by standard tools. Proactive screening and management of osteoporosis in people with diabetes are crucial for preventing fractures.
Area of Science:
- Endocrinology
- Metabolic Bone Disease
- Geriatric Medicine
Background:
- Type 2 diabetes (T2DM) and osteoporosis are prevalent, chronic conditions in aging populations.
- Diabetes-related skeletal fragility elevates fracture risk, often undetected by current tools like FRAX and DXA.
- Understanding the interplay between T2DM, bone metabolism, and fracture risk is critical.
Purpose of the Study:
- To review the pathophysiology of skeletal fragility in T2DM.
- To examine the impact of glucose-lowering medications on bone metabolism.
- To outline diagnostic and management strategies for osteoporosis in people with diabetes (PWD).
Main Methods:
- A literature search was performed on PubMed.
- Included English-language articles focusing on T2DM and osteoporosis or skeletal fragility.
- Selected articles of direct clinical relevance to diabetes practitioners.
Main Results:
- T2DM is linked to skeletal fragility via compromised bone remodeling and turnover.
- Risk factors for fractures in PWD include long duration, poor glycemic control, complications, muscle dysfunction, and certain medications (e.g., TZDs).
- DXA and FRAX underestimate fracture risk in diabetes; however, diabetes does not affect treatment response in post-menopausal women.
Conclusions:
- Fragility fracture risk assessment should be integrated into T2DM care.
- Physicians should proactively screen and manage osteoporosis in PWD.
- Consider bone health implications when choosing glucose-lowering agents for at-risk individuals.
Related Concept Videos
Bone Disorders
4.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.8K
Diabetes Mellitus: Type 2 and Gestational
3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Psychoneuroimmunology: Diabetes and Cancer
110
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
110
Diabetes Mellitus: Overview and Type I Subtype
4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Diabetes: Symptoms, Diagnosis, and Complications
1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Pathophysiology of Diabetes
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K


